| mRNA |
1S,3R-RSL-3 |
CTRPv2 |
pan-cancer |
AAC |
-0.09 |
0.006 |
| mRNA |
triazolothiadiazine |
CTRPv2 |
pan-cancer |
AAC |
0.081 |
0.006 |
| mRNA |
SB-525334 |
CTRPv2 |
pan-cancer |
AAC |
0.1 |
0.006 |
| mRNA |
MP470 |
GDSC1000 |
pan-cancer |
AAC |
0.092 |
0.006 |
| mRNA |
carboplatin:etoposide (40:17 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.08 |
0.007 |
| mRNA |
manumycin A |
CTRPv2 |
pan-cancer |
AAC |
0.086 |
0.007 |
| mRNA |
CHEMBL374350 |
CTRPv2 |
pan-cancer |
AAC |
0.1 |
0.007 |
| mRNA |
Tipifarnib |
FIMM |
pan-cancer |
AAC |
-0.32 |
0.008 |
| mRNA |
Oxaliplatin |
CTRPv2 |
pan-cancer |
AAC |
0.086 |
0.008 |
| mRNA |
tanespimycin:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.098 |
0.008 |